The Digital Apothecary

MAY 11, 2018

Being a Professor at a Pharmacy School. A reflection of roles, responsibilities, and changes faced with transitioning from a resident to a professor to a father. This past month, I was promoted to the rank of Associate Professor of Pharmacy Practice. I had started being an Assistant Professor in January of 2013. Before that, I had done a PGY-1 Pharmacy Practice Residency, and then a Geriatric Fellowship at the insitution that I am now a professor at, after deciding I'd like to stay on based on t

Documentation 52

Documentation Hospitals Patient Care 52

pharmaphorum

MAY 3, 2018

Change Together will be presenting a live webinar with leading figures from the patient advocacy community, who will debate how we can drive positive change for patients through improved education and awareness. This will be helpful for all advocates, as we hear and learn from our expert panel how their organizations are bringing about change. The panel and the topics they will be covering are as follows. • Dr.

52

52

Med Ed 101

MAY 30, 2018

Assessing medications in a frequent faller is something I do on a pretty regular basis. There are often multifactoral reasons for the falls, but as a pharmacist, our obvious focus is on the medications and how they might complicated our frequent faller’s situation. An 81 year old female has had an increasing number of falls. […]. The post Assessing Medications in a Frequent Faller – Case Scenario appeared first on Med Ed 101.

40

40

Med Ed 101

MAY 27, 2018

Here’s a case scenario involving the Prozac Wellbutrin interaction. A 64 year old male has severe depression. He is currently on Remeron 15 mg once daily, Prozac 80 mg once daily, and Abilify 10 mg once daily. He has been tried on just about every other SSRI and SNRI without any benefit. He is still […]. The post Prozac Wellbutrin Interaction – Case Scenario appeared first on Med Ed 101.

40

40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

MAY 23, 2018

There’s been a recent update from CMS that has started to be implemented. The F-Tags have been given a little facelift and renumbering. I’m a consultant pharmacist, so I’m going to focus on the changes in Pharmacy Services F-Tags. The pharmacy services F-Tags run between F755-F761. There are now seven possible pharmacy services F-Tags.

40

40

Med Ed 101

MAY 20, 2018

In the patient on numerous medications, drug interactions are always a constant concern. In the scenario below, I lay out some strategies to monitor the bupropion nortriptyline interaction with a brief description of what might happen on account of this drug-drug interaction. A 58 year old female has refractory depression and is managed by psychiatry. […].

40

40

Med Ed 101

MAY 16, 2018

Anticholinergic side effects are something that I see on nearly a daily basis. I’ve become accustomed at identifying these and trying to come up with a game plan to minimize these adverse effects. Here’s a few strategies for things I look out for on a medication list to try to help identify these adverse effects. […]. The post How to Spot Anticholinergic Side Effects appeared first on Med Ed 101.

40

40

Med Ed 101

MAY 9, 2018

As I’ve gotten into the online space, I’ve had quite a few influences and people I’ve admired from afar (literally really afar). Many I have never met in person, but from following them and having interactions on various social media platforms, I can tell they are great resources and care about what they do. These […]. The post Pharmacy Leaders – Who’s Leading the Discussion Online and Thinking Outside the Box appeared first on Med Ed 101.

40

40

Med Ed 101

MAY 6, 2018

This post on Hot Flashes and Breast Cancer was donated by Jiamin Liau, a clinical pharmacist from across the world in Australia. Thanks for your contribution! In patients with cancer, hot flashes and night sweats may be caused by the tumor, its treatment, or other conditions. Treatment for breast cancer and prostate cancer can cause […]. The post Hot Flashes and Breast Cancer appeared first on Med Ed 101.

40

40

Med Ed 101

MAY 2, 2018

Extended release products are a common method to deliver medications. There are certainly advantages to having medications delivered via this method, but there are also certain instances where this may not be advantageous. I’ll discuss some of the challenges and benefits with these products with some examples. The obvious benefit of extended release products is […].

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA